[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$flJlFQ79HI-maUZRduLUwN6_13KriY9ib_jkNUgWfKHo":8,"$fSqu8f03_N8Qz687sfh-wrBYnq66jP7gFz7yU2VF7H1w":55,"$fkO2vxJWD3Dtr_UUDHep_Tk6GoiFoki6MeQK3-CFC2Kk":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},65148,869732,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//qvhCCTIvcNBh6P1V3cjuUDfxcVOObxse.png","杨丰名","浙江大学医学院附属第二医院","肿瘤科","主治医师",41,0,"结肠癌治疗的化疗方案：科学认知与实用指南","","https://ystcdn.venuertc.com/venue/AI/cb37f862-1716-4f77-bd13-3a8334e0784c.jpg","\u003Cdiv id=\"material_title\" class=\"custom-colonchemo-title\">\n  \u003Ch1 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">结肠癌治疗的化疗方案：科学认知与实用指南\u003C/h1>\n\u003C/div>\n\n\u003Csection class=\"custom-colonchemo-section custom-bg-basic\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01. 结肠癌化疗药物基础🔬\u003C/h2>\n  \u003Cdiv class=\"custom-colonchemo-content\">\n    \u003Cp>\n      说起来，药物治疗在结肠癌辅助和巩固方案中起着重要作用。常见的化疗药物类别包括细胞毒类药物和分子靶向药物。细胞毒类如铂类化合物（比如奥沙利铂）、氟尿嘧啶（如5-FU）、伊立替康，以及拓扑异构酶抑制剂等。靶向药物多以抗血管生成和抑制信号通路为主，例如贝伐珠单抗。这些药物的作用机制主要是干扰癌细胞分裂或阻断关键信号，为后续治疗打基础。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>化疗药物通常通过静脉滴注或口服方式给药\u003C/li>\n      \u003Cli>作用机制各有不同，重点是干扰肿瘤细胞活性\u003C/li>\n      \u003Cli>不同药物可能搭配使用，根据个体方案调整\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"custom-colonchemo-emoji\">🩺\u003C/span>\n  \u003C/div>\n\u003C/section>\n\u003Csection class=\"custom-colonchemo-section custom-bg-dosage\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02. 常见化疗药物成分与剂型💊\u003C/h2>\n  \u003Cdiv class=\"custom-colonchemo-content\">\n    \u003Cp>\n      结肠癌化疗涉及的药品较多，常用成分包括：\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>奥沙利铂\u003C/strong>：注射液剂型，常见于FOLFOX方案。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>伊立替康\u003C/strong>：注射液，拓扑异构酶Ⅰ抑制剂。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>氟尿嘧啶（5-FU）\u003C/strong>：注射制剂及口服片。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>卡培他滨\u003C/strong>：口服片剂，可由肝脏代谢为5-FU。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>贝伐珠单抗\u003C/strong>：靶向抗体注射液，抑制肿瘤血管生成。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      注射型药物需由专业人员操作；口服药需要严格按医嘱剂量服用，不可随意增减或漏服。\n    \u003C/p>\n    \u003Cp>\n      有一位70岁男性患者术后联合使用奥沙利铂、伊立替康和贝伐珠单抗，每种药物规格为标准剂量，治疗期间无明显过敏反应，为个别用药案例参考。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\u003Csection class=\"custom-colonchemo-section custom-bg-timing\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03. 化疗药物的用法用量⏱️\u003C/h2>\n  \u003Cdiv class=\"custom-colonchemo-content\">\n    \u003Cp>\n      用药的时间和方法极为关键。奥沙利铂、伊立替康、5-FU等药物多为静脉注射，需在医院实施。口服制剂如卡培他滨常在餐后30分钟内服用，以减少潜在的胃肠刺激。贝伐珠单抗需每2~3周静脉滴注一次，由医生根据体重和方案确定剂量。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>正确做法：\u003C/strong>遵循医师指示，每次用药均需定点、定量，不宜自行更改换药或停药方案。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>剂量调整：\u003C/strong>老年患者和肝肾功能受损者需特别注意剂量调控，定期监测血象和肝肾功能。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"custom-colonchemo-emoji\">📅\u003C/span>\n  \u003C/div>\n\u003C/section>\n\u003Csection class=\"custom-colonchemo-section custom-bg-interaction\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04. 化疗药物相互作用 🔁\u003C/h2>\n  \u003Cdiv class=\"custom-colonchemo-content\">\n    \u003Cp>\n      化疗药物之间存在一定程度的相互影响。例如，奥沙利铂与5-FU可产生协同作用，对肿瘤细胞杀伤增强。卡培他滨与华法林有明确相互作用，可能加重抗凝风险；贝伐珠单抗不宜与某些血管收缩药物联合用药，以免增加血栓风险。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>需要注意：\u003C/strong>服用升白细胞药物（如重组粒细胞刺激因子）期间应间隔使用化疗药。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>饮食关系：\u003C/strong>卡培他滨需在餐后服用，不宜空腹以防胃肠道刺激。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>特别提醒：\u003C/strong>合并使用其他药物前，务必咨询医生或药师，逐一核查相互作用风险。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"custom-colonchemo-emoji\">⚠️\u003C/span>\n  \u003C/div>\n\u003C/section>\n\u003Csection class=\"custom-colonchemo-section custom-bg-group\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05. 特殊人群用药调整 👨‍👩‍👧‍👦\u003C/h2>\n  \u003Cdiv class=\"custom-colonchemo-content\">\n    \u003Cp>\n      老年人、体重偏低患者以及肝肾功能不全者用药时需特别调整。比如，70岁男性患者联合应用升白细胞药物时，由医生根据体重和血象指标调整剂量。孕妇、哺乳期女性以及儿童通常不建议使用大多数细胞毒性化疗药物，除非有特殊情况且经过风险评估。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>\n        老年患者应结合营养状况和基础疾病适当减少剂量，定期监测。\n      \u003C/li>\n      \u003Cli>\n        肝肾功能受限者应提前检查相关生化指标，调整或更换药品种类。\u003C/li>\n      \u003Cli>\n        儿童用药需参考特殊儿童标准剂量，严禁“成人减量”类做法。\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/section>\n\u003Csection class=\"custom-colonchemo-section custom-bg-sideeffect\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06. 常见不良反应及处理🩹\u003C/h2>\n  \u003Cdiv class=\"custom-colonchemo-content\">\n    \u003Cp>\n      使用结肠癌化疗药物最常见的反应包括骨髓抑制、胃肠道反应（如恶心、呕吐）、神经系统反应（尤其奥沙利铂引起的周围神经病变）、肾功能异常等。针对骨髓抑制患者，临床常用升白细胞药物（如重组粒细胞刺激因子）口服辅助；胃肠不适可用5-HT3受体拮抗剂减少恶心。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>\n        一名患者化疗期间服用益生菌制剂，配合合理饮食，有助于改善肠道微生态，减轻腹泻发生率。\n      \u003C/li>\n      \u003Cli>\n        说明书提示：奥沙利铂周围神经病变发生率约30-40%，多数可逆，但严重时需及时停药。\n      \u003C/li>\n      \u003Cli>\n        发生恶心、呕吐时，建议服用止吐药并调整饮食习惯。\u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      出现严重不适（如持续发热、出血、明显神经症状时），务必及时到医院就诊，不宜拖延或自行处理。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\u003Csection class=\"custom-colonchemo-section custom-bg-storage\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07. 药品储存、有效期与处理方法📦\u003C/h2>\n  \u003Cdiv class=\"custom-colonchemo-content\">\n    \u003Cp>\n      化疗药品储存有明确要求。注射型药物（如奥沙利铂、贝伐珠单抗）通常需冷藏，避免光照和高温暴露。口服型药品（如卡培他滨、升白细胞药物）建议置于阴凉干燥处，避免受潮。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>\n        药品开封后按说明书标注有效期使用，逾期不用或发现变色、结块时应丢弃。\n      \u003C/li>\n      \u003Cli>\n        家庭自备药物应远离儿童，标注开封日期，封口严密。\n      \u003C/li>\n      \u003Cli>\n        过期药品不可自行焚烧或丢入下水道，可送至指定回收点统一处理。\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/section>\n\u003Csection class=\"custom-colonchemo-section custom-bg-missdose\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08. 漏服与过量的应对措施📖\u003C/h2>\n  \u003Cdiv class=\"custom-colonchemo-content\">\n    \u003Cp>\n      漏服口服化疗药或辅助药品时，正确做法是尽快补服。如果临近下次服药，则按原计划服一剂，不可擅自多补药量。过量服用时可能增加骨髓抑制、神经损伤等风险，出现异常反应务必立即就医。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>\n        静脉注射药物应有医疗人员配合，不存“漏服”问题；若错过预约，应尽早联系医院重新安排。\u003C/li>\n      \u003Cli>\n        所有化疗药物都不可自行加量补服，以免严重毒副作用。\u003C/li>\n      \u003Cli>\n        家庭成员应协助监督药品使用，做好用药记录。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/section>\n\u003Csection class=\"custom-colonchemo-section custom-bg-summary\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09. 总结与安全用药提醒🔑\u003C/h2>\n  \u003Cdiv class=\"custom-colonchemo-content\">\n    \u003Cp>\n      化疗药物的作用复杂，用药细节和安全性至关重要。从正确选择成分剂型、合理搭配药物、关注特殊人群调整，到留意不良反应、储存细则和漏服应急，每一步都关乎治疗效果和安全。实际用药案例显示，规范搭配升白细胞药、益生菌、质子泵抑制剂等，能够提升患者耐受性和生活质量。\n    \u003C/p>\n    \u003Cp>\n      关键做好三点：①严格遵守医生用药指示；②配合专业药师核查药物相互作用；③遇到过敏、严重不适时及时就医。安全、规范的用药习惯，是获得最佳治疗效果的前提。\n    \u003C/p>\n    \u003Cspan class=\"custom-colonchemo-emoji\">👍✨\u003C/span>\n  \u003C/div>\n\u003C/section>\n\u003Csection class=\"custom-colonchemo-section custom-bg-reference\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10. 文献引用📚\u003C/h2>\n  \u003Cdiv class=\"custom-colonchemo-content\">\n    \u003Cul>\n      \u003Cli>\n        Grothey, A., Sargent, D., Goldberg, R. M., & Schmoll, H. J. (2007). Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the chemotherapy regimen. \u003Ci>Journal of Clinical Oncology, 25\u003C/i>(23), 3316-3324.\n      \u003C/li>\n      \u003Cli>\n        Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., ... & Kabbinavar, F. (2004). Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. \u003Ci>New England Journal of Medicine, 350\u003C/i>(23), 2335-2342.\n      \u003C/li>\n      \u003Cli>\n        Van Cutsem, E., Köhne, C. H., Láng, I., et al. (2009). Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. \u003Ci>New England Journal of Medicine, 360\u003C/i>(14), 1408-1417.\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/section>\n\n\u003Cstyle>\n.custom-colonchemo-title {\n  background: linear-gradient(90deg, #a3cef1 0%, #e0eafc 100%);\n  padding: 32px 0 24px 0;\n  text-align: center;\n  margin-bottom: 16px;\n  border-radius: 16px;\n}\n\n.custom-colonchemo-title h1 {\n  font-size: 42px;\n  color: #205375;\n  letter-spacing: 1.5px;\n  font-weight: bold;\n  margin: 0;\n}\n\n.custom-colonchemo-section {\n  margin: 32px 0 28px 0;\n  padding: 32px 32px 20px 32px;\n  border-radius: 16px;\n  box-shadow: 0 3px 12px #22577a1c;\n  position: relative;\n  max-width: 920px;\n  margin-left: auto;\n  margin-right: auto;\n}\n\n.custom-colonchemo-section h2 {\n  font-size: 28px;\n  font-weight: bold;\n  margin-top: 0;\n  margin-bottom: 18px;\n  color: #22577a;\n  padding-top: 6px;\n  background: linear-gradient(90deg, #e3f2fd 60%, #c4e0fc 100%);\n  border-radius: 8px;\n  padding-bottom: 6px;\n  padding-left: 20px;\n}\n\n.custom-bg-basic {\n  background: linear-gradient(120deg, #f0f6fc 70%, #b7e4c7 100%);\n}\n\n.custom-bg-dosage {\n  background: linear-gradient(120deg, #eaf7fa 80%, #f7f7c5 100%);\n}\n\n.custom-bg-timing {\n  background: linear-gradient(120deg, #fbeee6 85%, #e6f5fb 100%);\n}\n\n.custom-bg-interaction {\n  background: linear-gradient(120deg, #e6fcf5 90%, #f0e6fc 100%);\n}\n\n.custom-bg-group {\n  background: linear-gradient(120deg, #fdeef2 90%, #e6fcfc 100%);\n}\n\n.custom-bg-sideeffect {\n  background: linear-gradient(120deg, #fceecb 85%, #cbe2fc 100%);\n}\n\n.custom-bg-storage {\n  background: linear-gradient(120deg, #e5ecf6 80%, #f6e0fa 100%);\n}\n\n.custom-bg-missdose {\n  background: linear-gradient(120deg, #e5f6e2 80%, #faf5e5 90%);\n}\n\n.custom-bg-summary {\n  background: linear-gradient(90deg, #f3f5ee 80%, #d5eaf6 100%);\n}\n\n.custom-bg-reference {\n  background: linear-gradient(90deg, #e8edea 90%, #c5ddee 100%);\n}\n\n.custom-colonchemo-content {\n  font-size: 19px;\n  color: #144063;\n  line-height: 2.1em;\n  padding-top: 7px;\n}\n\n.custom-colonchemo-content ul {\n  list-style: disc;\n  padding-left: 2.5em;\n  margin-bottom: 18px;\n  margin-top: 7px;\n}\n\n.custom-colonchemo-content li {\n  font-size: 18px;\n  margin-bottom: 7px;\n  line-height: 1.8em;\n}\n\n.custom-colonchemo-content p {\n  margin-bottom: 14px;\n}\n\n.custom-colonchemo-emoji {\n  font-size: 38px;\n  position: absolute;\n  right: 32px;\n  top: 24px;\n  opacity: 0.78;\n}\n\n@media (max-width: 620px) {\n  .custom-colonchemo-title h1 {\n    font-size: 28px;\n  }\n  .custom-colonchemo-section {\n    padding: 16px 10px 12px 10px;\n    max-width: 100%;\n  }\n  .custom-colonchemo-section h2 {\n    font-size: 20px;\n    padding-left: 12px;\n  }\n  .custom-colonchemo-content {\n    font-size: 16px;\n  }\n  .custom-colonchemo-content li {\n    font-size: 15px;\n  }\n  .custom-colonchemo-emoji {\n    font-size: 28px;\n    right: 14px;\n    top: 12px;\n  }\n}\n\u003C/style>\n","\u003Cdiv id=\"material_title\" class=\"custom-colonchemo-title\">\n  \u003Ch1 style=\"color: rgb(44, 62, 80); margi",582,"2025-08-28 13:59:58","结肠癌, 化疗, 肿瘤药物, 射线治疗, 老年患者, 药品相互作用, 治疗副作用, 规范用药","本文深入分析了结肠癌化疗药物的基础知识与应用，如奥沙利铂、伊立替康、贝伐珠单抗等，适合患者及家属了解用药安全和有效性。","2025-09-08 14:49:06",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]